Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Arrayit Corp. (OTC: ARYC).

Full DD Report for ARYC

You must become a subscriber to view this report.


Recent News from (OTC: ARYC)

Arrayit Corporation Announces New Clinical Licensure from the Centers for Medicare and Medicaid Services
Sunnyvale, May 09, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces receipt of a new clinical licensure from the Centers for Medicare and Medicaid Services (CMS), which oversees the Clinical Laboratory Improvement Amend...
Source: GlobeNewswire
Date: May, 09 2018 08:30
Avant Diagnostics, Inc. (AVDX) Noninvasive, Pre-Symptomatic Ovarian Cancer Diagnostic Platform Could Also Address Many Other Diseases
According to the latest data from the American Cancer Society, in the U.S. alone over 21,000 women will be diagnosed with ovarian cancer this year, and more than 14,000 will perish from the disease. In most cases, ovarian cancer is detected by a combination of symptomatic expression and/or t...
Source: DreamTeamNetwork
Date: December, 16 2015 09:30
Arrayit Corporation Receives Approval for Ten Million Share Dividend in AVDX Stock to ARYC Shareholders
SUNNYVALE, CA / ACCESSWIRE / December 7, 2015 / Arrayit Corporation (OTC: ARYC ), a life sciences company, announces today it has received Financial Industry Regulatory Authority (FINRA) approval to dividend ten million common shares of its ownership in Avant Diagnostics (OTCQB: AVDX ) to ...
Source: ACCESSWIRE IA
Date: December, 07 2015 11:47
Arrayit Corporation Awards $3M Stock Dividend to ARYC Shareholders
SUNNYVALE, CA / ACCESSWIRE / September 30, 2015 / Arrayit Corporation (OTCQB: ARYC ), a life sciences company, announces today that the Arrayit Board of Directors has voted unanimously to issue 10,000,000 common shares of its subsidiary Avant Diagnostics (OTCQB: AVDX ) to ARYC common share...
Source: ACCESSWIRE IA
Date: September, 30 2015 15:12
DUE DILIGENCE REPORT: Arrayit Corp. Shares a Bargain Now - Small Cap Street
DUE DILIGENCE REPORT: Arrayit Corp. Shares a Bargain Now - Small Cap Street
Source: OTC Markets
Date: September, 28 2015 00:00
Seeking FDA Clearance for Innovative Diagnostic Tool
Avant Diagnostics, Inc. (OTC: AVDX) is a medical diagnostic technology company specializing in large panel biomarker screening. The company’s first test, OvaDx®, is being developed in conjunction with Arrayit Corporation (OTCQB: ARYC) as the market’s first large panel biom...
Source: DreamTeamNetwork
Date: August, 20 2015 09:30
Fueling Exploration of the Human Genome with Innovative Products and Services
Arrayit (OTC:ARYC) is a leading life sciences company providing innovative products and services to empower exploration of the human genome, as well as the genomes of plants and animals. The company’s patented microarray manufacturing platform and proprietary VIP™ genotyping te...
Source: DreamTeamNetwork
Date: July, 08 2015 09:30
Small Cap IR - Empowering the Age of Genetic Enlightenment
Small Cap IR - Empowering the Age of Genetic Enlightenment
Source: OTC Markets
Date: June, 30 2015 00:00

 


About Arrayit Corp. (OTC: ARYC)

Logo for Arrayit Corp. (OTC: ARYC)

lt p gt Arrayit leads professionals in the microarray industry by developing, manufacturing and marketing life science tools and integrated laboratory platforms for the analysis of genetic variation, biological function, and diagnostics. Arrayit provides it specialized equipment, tools, microarray manufacturing services to more than , research laboratories, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies around the globe. lt /p gt

 

 

 

Current Management

  • Rene A. Schena / CEO
  • Mark Schena / President, Secretary, Treasurer, CTO
  • Todd Martinsky / EVP
  • Philip Ruben / Securities Counsel

Current Share Structure

  • Market Cap: $11,489,302 - 03/09/2018
  • Authorized: 480,000,000 - 04/15/2015
  • Issue and Outstanding: 696,321,311 - 11/20/2015
  • Float: 30,712,404 - 04/15/2015

 


Recent Filings from (OTC: ARYC)

Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: March, 22 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 05 2016
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 05 2016
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 22 2016
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 30 2015
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 23 2015
All other definitive information statements
Filing Type: DEF 14CFiling Source: edgar
Filing Date: December, 22 2015
Preliminary proxy statement containing all other information
Filing Type: PRE 14CFiling Source: edgar
Filing Date: December, 10 2015
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 07 2015
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: November, 23 2015

 

 


Daily Technical Chart for (OTC: ARYC)

Daily Technical Chart for (OTC: ARYC)


Stay tuned for daily updates and more on (OTC: ARYC)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ARYC)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ARYC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of ARYC and does not buy, sell, or trade any shares of ARYC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/